EPISODE · Feb 6, 2023 · 32 MIN
Episode 24: Five Years after Approval of Voretigene Neparvovec – What is The Future of Retinal Gene Therapy?
from Talking Euretina · host Whipsmart Media
In this podcast, Mark Penessi is joined by Isabelle Audo and Bart Leroy to discuss the impact of Luxturna and how gene therapy products will affect the treatment of inherited retinal diseases (IRD) in the future.
Embed this episode
NOW PLAYING
Episode 24: Five Years after Approval of Voretigene Neparvovec – What is The Future of Retinal Gene Therapy?
0:00
32:51
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Talking Euretina?
This episode is 32 minutes long.
When was this Talking Euretina episode published?
This episode was published on February 6, 2023.
Can I download this Talking Euretina episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!